![J. Christopher Prue](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
J.
Christopher Prue worked as a Senior Director-Regulatory Affairs at Rani Therapeutics Holdings, Inc. from 2021 to 2023.
Prior to that, he held positions as a Principal at The Upjohn Co., Incara Pharmaceuticals Corp., and Purdue Pharma LP.
He also served as the VP-Regulatory Affairs & Quality Assurance at BioDelivery Sciences International, Inc., Vice President-Regulatory Affairs at AtheroGenics, Inc., Flexion Therapeutics, Inc., and ABIONYX Pharma SA. Mr. Prue completed his undergraduate degree at Purdue University and obtained an MBA from Western Michigan University.
| Unternehmen | Position | Ende |
|---|---|---|
| RANI THERAPEUTICS HOLDINGS, INC. | General Counsel | 01.09.2023 |
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | General Counsel | 14.07.2009 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | General Counsel | - |
| FLEXION THERAPEUTICS, INC. | General Counsel | - |
The Upjohn Co.
 The Upjohn Co. Pharmaceuticals: MajorHealth Technology Manufacturer of pharmaceuticals | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 10 |
|---|---|
The Upjohn Co.
The Upjohn Co. Pharmaceuticals: MajorHealth Technology Manufacturer of pharmaceuticals | Health Technology |
Incara Pharmaceuticals Corp.
 Incara Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cardiovascular and pulmonary diseases | Health Technology |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Health Technology |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Purdue Pharma LP
 Purdue Pharma LP Medical DistributorsDistribution Services Distributes medicines | Distribution Services |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western Michigan University
 Western Michigan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ABIONYX Pharma SA
 ABIONYX Pharma SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel HDL therapies for the treatment of cardiovascular and metabolic diseases | Health Technology |
Rani Therapeutics Holdings, Inc.
 Rani Therapeutics Holdings, Inc. BiotechnologyHealth Technology Engages in research and development of orally administered biological products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
